Tyler Skaggs' Death Reportedly Subject of DEA Investigation

September 19, 2019

The U.S. Drug Enforcement Administration is investigating how Los Angeles Angels pitcher Tyler Skaggs acquired the drugs that were found in his system at the time of his death, according to ESPN’s T.J. Quinn.

Skaggs was found unresponsive in his hotel room in Southlake, Texas on July 1 prior to the first game of a series against the Texas Rangers. The game that night was postponed.

On Aug. 30, an autopsy report publicly released revealed that the 27-year-old had fentanyl, oxycodone and ethanol in his system.

A senior DEA official told ESPN that the agency often investigates cases involving fentanyl — a synthetic opioid pain reliever that can be 50 to 100 times more powerful than morphine, according to the Centers for Disease Control and Prevention.

When contacted by RADIO.COM, a DEA spokesperson said, "we cannot comment on an ongoing investigation."

A statement released by Skaggs’ family at the time of the autopsy report implicated the potential involvement of an Angels employee.

“We were shocked to learn that it may involve an employee of the Los Angeles Angels,” the statement said. “We will not rest until we learn the truth about how Tyler came into possession of these narcotics, including who supplied them.”

No Angels employee has been publicly identified in connection to Skaggs’ death, or being targeted in the investigation.

“We continue to cooperate with law enforcement on this important matter,” an Angels team spokesperson told ESPN.

While opioids are considered a banned substance by the MLB, players are not currently tested for them. Skaggs’ death has prompted MLB to begin discussions on changing that, per ESPN’s Jeff Passan.

The topic of testing for opioids was recently discussed on RADIO.COM’s “Swings and Mrs.” podcast.